The Surprising Carbon Impact of Science: Progress on the Global Race to Zero

18:30 – 19:30 (EET)

Biotech & Pharma are among the world’s largest carbon-emitting industries and must be a part of the global climate solution. The industries’ climate commitments are not ambitious enough to keep warming below the 1.5˚C threshold. This study quantifies the carbon impact of the upstream and downstream value chain of biotech & pharma by evaluating Scope 3 emissions and reports opportunities for positive change while charting the industry’s progress towards meeting Paris Climate Agreement targets.

Gain an understanding of the surprisingly high carbon impact of biotech & pharma industry and identify the key leverage points within the industry’s value chain in order to affect change.

Join the global green lab movement to transform the scientific industry through sustainability.